| Grupo Medico De Cidra, Inc. | |
|
49 Calle Jose De Diego Cidra PR 00739-3361 | |
| (787) 739-5099 | |
| (787) 520-7101 |
| Full Name | Grupo Medico De Cidra, Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 49 Calle Jose De Diego, Cidra, Puerto Rico |
| Authorized Official Name and Position | Alberto Fernandez (VICE PRESIDENT) |
| Authorized Official Contact | 7877395099 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Grupo Medico De Cidra, Inc. Po Box 730 Cidra PR 00739-0730 Ph: (787) 739-5099 | Grupo Medico De Cidra, Inc. 49 Calle Jose De Diego Cidra PR 00739-3361 Ph: (787) 739-5099 |
| NPI Number | 1013048248 |
|---|---|
| Provider Enumeration Date | 03/08/2007 |
| Last Update Date | 08/29/2016 |
| Medicare PECOS PAC ID | 5294020384 |
|---|---|
| Medicare Enrollment ID | O20160829001998 |
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013048248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | (* (Not Available)) | Primary |
| Provider Name | Zulma L Munoz Camacho |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1649380312 PECOS PAC ID: 3072619261 Enrollment ID: I20070504000160 |
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
| Provider Name | Andres Ramos Conde |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1982770178 PECOS PAC ID: 4587747456 Enrollment ID: I20080215000166 |
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
| Provider Name | Alberto Fernandez Torres |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1417943960 PECOS PAC ID: 9436306032 Enrollment ID: I20120905000167 |
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
| Provider Name | Jorge L Calderon |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194850289 PECOS PAC ID: 6800044850 Enrollment ID: I20120917000196 |
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
| Provider Name | Roberto Rivera |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1417038969 PECOS PAC ID: 1658507934 Enrollment ID: I20131114001054 |
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
News Archive
The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).
Hospital Compare, a new service, will give Americans the ability to compare the quality of care in nearly all of the nation's hospitals using quality information available from the Centres for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA).
A nationwide survey of business executives by Crain Communications Inc about the recent federal health care reform law has found that a majority of U.S. employers are unlikely to cease offering health care benefits to their workers.
In this age of the 24-hour news cycle, instant access to all information everywhere, PubMed, LinkedIn, Facebook, Twitter and hundreds of other ways to glean and share knowledge beyond the traditional stack of printed journals delivered to their door, physicians continue to struggle to arm themselves with the most effective therapies.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
› Verified 7 days ago
Beatriz Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: Bo Beatriz Car # 1 Km 51.8, Cidra, PR 00739 Phone: 787-689-0600 Fax: 787-738-8700 | |
Centro De Servicios Salud Cidra Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Calle Palmer, Cidra, PR 00739 Phone: 787-469-2289 | |
Cidra & Montana, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Calle Jose De Diego 49, Cidra, PR 00739 Phone: 787-739-5099 | |
Cossma Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Ave El Jibaro Carr 172 Km 13.5, Cidra, PR 00739 Phone: 787-739-8182 | |
Integral Med Pr Psc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Centro Comercial Villa Del Carmen Local 109, Cidra, PR 00739 Phone: 787-714-3823 Fax: 787-714-3819 | |
Oficina Medica Del Dr. J.a. Burgos, C.s.p. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Centro De Salud Familiar Menonita Carr. 172 Ave. El, Jibaro Km.3.3 Oficina 107, Cidra, PR 00739 Phone: 787-714-0144 Fax: 787-714-0230 |